Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2013 Jan;47(1):33-44.
doi: 10.1097/MCG.0b013e3182688c15.

The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis

Affiliations
Meta-Analysis

The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis

Raxitkumar Jinjuvadia et al. J Clin Gastroenterol. 2013 Jan.

Abstract

Background: There has been constant speculation about the association between metabolic syndrome (MetS) and colorectal neoplasia (CN); however, the published results are conflicting. The aims of this study are to conduct a systematic search, and assess the literature to determine the available evidence on the association between these two conditions.

Methods: Meta-analysis was conducted based on relevant studies identified through a systematic literature review from PubMed, OvidSP, and Cochrane database during January 1980 to July 2011. A combined analysis was performed, followed by a subgroup analyses stratified by the study design, type of colorectal lesions, and sex. Publication bias was assessed using the Begg and Egger tests and visual inspection of funnel plot.

Results: Eighteen studies were included in the final analysis. Overall, MetS was associated with 34% increase in the risk of CN [summary relative risk (RR), 1.34; 95% confidence interval (CI), 1.24-1.44]. The association between MetS and CN was found to be statistically significant in separate analysis for both case-control studies (summary RR, 1.58; 95% CI, 1.44-1.73) and cohort studies (summary RR, 1.21; 95% CI, 1.13-1.29). The association remained significant when analyses were restricted by type of colorectal lesions (colorectal cancer: RR, 1.30; 95% CI, 1.18-1.43; colorectal adenoma: RR, 1.37; 95% CI, 1.26-1.49). Further subgroup analysis by sex showed significant association between MetS and CN in both male and female population.

Conclusions: Our meta-analysis showed significant association between presence of MetS and CN. These results may help in identifying high-risk individuals at early stage, who might benefit from targeted colorectal cancer screening intervention.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Authors declared no conflicts of interest with this work.

Figures

Figure 1
Figure 1
Flowchart of study selection
Figure 2
Figure 2
Forest plot: Association between metabolic syndrome and colorectal neoplasm (adenoma and cancer combined). CRN – colorectal neoplasm; CRC – colorectal cancer; CC – colon cancer; RC – rectal cancer; CRA – colorectal adenoma; CRCA – colorectal cancer and adenoma; m – male; f – female.
Figure 3
Figure 3
Forest plot: Association between metabolic syndrome and colorectal adenoma. CRA – colorectal adenoma; m – male; f – female
Figure 4
Figure 4
Forest plot: Association between metabolic syndrome and colorectal cancer. CRC – colorectal cancer; CC – colon cancer; RC – rectal cancer; CRA – colorectal adenoma; m – male; f – female.
Figure 5
Figure 5
Funnel plots for publication bias (a) Metabolic syndrome and colorectal neoplasm (adenoma and cancer combined) (b) Metabolic syndrome and colorectal adenoma (c) Metabolic syndrome and colorectal cancer

Comment in

References

    1. Cancer Facts and Figures American Cancer Society. 2011.
    1. Surveillance Epidemiology and End Results. 2011 Available from: http://seer.cancer.gov/statfacts/html/colorect.html#risk.
    1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA. 2001;285(19):2486–97. - PubMed
    1. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245–50. - PubMed
    1. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 20032006. Natl Health Stat Report. 2009;(13):1–7. - PubMed

Publication types

MeSH terms